Latest Breaking News On - தலை ஆஃப் தி புற்றுநோய் ஆராய்ச்சி - Page 1 : comparemela.com

Credit: Tel Aviv University Groundbreaking research from Tel Aviv University may lead to a significant breakthrough in the battle against deadly brain cancer. To begin with, the researchers identified a failure in the brain s immune system, leading to the amplification of cell division and spread of Glioblastoma cancer cells. The failure results partially from the secretion of a protein called P-Selectin (SELP), which, when bound to its receptor on the brain immune cells, alters their function so that instead of inhibiting the spread of cancer cells, they do the opposite, enabling them to proliferate and penetrate brain tissues. At the next stage of the study, the researchers were able to inhibit the secretion of the SELP protein, thereby neutralizing the failure in the immune system, restoring its normal activity, and blocking the spread of this incurable cancer. The international research team was led by Prof. Ronit Satchi-Fainaro, Director of the Cancer Biology Research Center a

United statesEilam yeiniRonit satchi fainaroAsaf madiJohns hopkins universityIsrael cancer research fundNature communicationsHead of the cancer researchIsrael science foundationLieber instituteIsrael cancer associationMorris kahn foundationCancer biology research centerKadar family awards for outstanding researchTel aviv sourasky medical center ichilovEuropean research council